Pharma & Healthcare contributed to Rs. 900cr electoral bonds.

Source: Indian express At least 30 pharma and healthcare companies bought electoral bonds worth over Rs 5 crore each, adding up to around Rs 900 crore, reveals the electoral bond data released on Thursday. This accounts for about 7.4% of the total Rs 12,155 crore amount for which the data was released. The top buyers include Yashoda […]
Govt releases guidelines to curb unethical pharma sector practices

Source: Indian Express In its latest guidelines to prevent unethical pharma industry practices that can influence healthcare professionals, the Union government has allowed firms to arrange medical education workshops and provide research grants for healthcare professionals, provided these are done in a transparent manner. “…Conference, seminar, workshop, etc. should only be allowed through a well-defined, […]
A single pharma company transforming country’s economy

Source: Money Control From both a biomedical and economic point of view, the success of the new class of weight-loss drugs is something to behold. Not only are they a remarkable scientific achievement, but — in the case of Ozempic and Wegovy, both made by Novo Nordisk — they are a huge boon to the […]
Grey market alert: Celeb-backed weight-loss meds smuggled into India

In Short A surge in demand among affluent Indians for weight-loss medications touted in showbiz circles has led to a concerning trend — drugs like Ozempic from Denmark’s Novo Nordisk and Mounjaro from America’s Eli Lilly are illicitly entering Indian pharmacies, sidestepping regulatory checks, an India Today investigation has found. Pooja and her employer Amit […]
Drugs regulator plans standards overhaul in India

Source: LiveMint New Delhi: With the Indian pharmaceutical industry increasingly coming under the scanner globally, the Central Drugs Standard Control Organisation (CDSCO) is conducting a major exercise for improving the quality, safety and efficacy of biological products. The apex drug regulator has come up with the latest guidelines on biological products such as vaccines, biological, […]
Why are pharma MNCs reducing India footprint?

Source: Times Of India Late on Feb 16, Swiss pharma major Novartis made a brief announcement that it had started a “strategic review” of its listed entity, Novartis India Limited, which includes an assessment of its shareholding in the subsidiary. Exactly three months ago, UK biggie AstraZeneca had also announced it was exiting manufacturing in […]
Exclusive: Govt mulling new PLI scheme for pharma sector

Source: Money Control The government is mulling over introducing a new production-linked incentive (PLI) scheme for the pharmaceutical sector to boost the production of key chemicals critical to the manufacture of active pharmaceutical ingredients (APIs). In doing so, it aims to reduce Indian companies’ dependence on China for such supplies, sources told Moneycontrol. “The entire value chain […]
Pharma MSMEs resent new norm

Source: Tribune India The Himachal Drug Manufacturers’ Association (HDMA) has sought relaxation in the 45-day payment norm for industries having a turnover of Rs 100 crore and Rs 50 crore for one year and two years, respectively. The new provision, introduced under Section 43 B of the Income Tax Act, would be implemented from the […]
Indian pharma Industry to log 8-10% revenue growth in FY24

India’s pharmaceutical industry is expected to have a revenue growth of 8-10 percent in Financial Year 2024 (FY24), ratings agency ICRA has said in a report. Growth is likely to be driven by price increases, new products, and health care services expanding in semi-urban and rural areas, said the report based on data from ICRA’s sample […]
15 Countries With Highest Pharmaceutical Spend Per Capita

Source: Yahoo In this article, we will be taking a look at the 15 countries with highest pharmaceutical spend per capita. If you are not interested in learning about the global pharmaceutical market, head straight to the 5 Countries With Highest Pharmaceutical Spend Per Capita. In the landscape of global healthcare expenditure, certain countries stand out […]